CLINICAL_TRIALS ClinicalTrials.gov record update

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05059444
Title field or adapter rule: {'original_value': 'ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At: 2026-10-31T23:27:25.928266+00:00
Published At: 2026-09-14T00:00:00+00:00
Record Updated At: 2026-09-14
Source Retrieved At: 2026-10-31T22:17:56.788771+00:00
Timestamp Basis: ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation: ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

protocolSection.conditionsModule.conditions: ["Bladder Carcinoma", "Ureter Carcinoma", "Renal Pelvis Carcinoma", "Non-small Cell Lung Cancer", "Invasive Breast Carcinoma", "Cutaneous Melanoma", "Esophageal Carcinoma", "Gastroesophageal Junction Carcinoma", "Gastric Adenocarcinoma", "Pancreatic Adenocarcinoma", "Squamous Cell Carcinoma of the Head and Neck", "Epithelial Ovarian Carcinoma", "Fallopian Tube Carcinoma", "Endometrial Carcinoma", "Renal Cell Carcinoma", "Rectal Adenocarcinoma", "Colon Adenocarcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct: {"date": "2026-09-14", "type": "ACTUAL"}
protocolSection.identificationModule.nctId: "NCT05059444"
protocolSection.identificationModule.officialTitle: "ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: null
protocolSection.statusModule.resultsFirstPostDateStruct: null

{'armGroupLabels': ['Cohort 10: Endometrial carcinoma', 'Cohort 11: High-risk renal cell carcinoma', 'Cohort 12: Colorectal adenocarcinoma', 'Cohort 1: Muscle invasive carcinoma of the bladder, ureter, or renal pelvis (stage II-III)', 'Cohort 2: Non-small cell lung cancer (stage IB-III)', 'Cohort 3: Invasive breast carcinoma with hormone receptor and HER2 status', 'Cohort 4: Stage IIB-III cutaneous melanoma or limited (resectable) stage IV melanoma', 'Cohort 5: Esophageal or gastroesophageal junction carcinoma (stage II-III)', 'Cohort 6: Gastric adenocarcinoma (stage II-III)', 'Cohort 7: Pancreatic adenocarcinoma', 'Cohort 8: Invasive squamous cell carcinoma of the head and neck', 'Cohort 9: High-risk epithelial ovarian or Fallopian tube carcinoma'], 'description': 'Guardant Reveal is a minimal residual disease (MRD) panel for use in recurrence detection of early-stage solid tumors.', 'name': 'Guardant Reveal', 'type': 'DIAGNOSTIC_TEST'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.